Certified by Founder Lodge
SymBiosis(US)
United States - Bentonville, AR
INVESTOR
1 Disclosed Funding Rounds $145,000,000
3 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
SymBiosis is an investment firm focused on advancing biotherapeutics innovations for serious and life-threatening diseases. The firm invests in groundbreaking medicines across disease area, f
| Company | Date | Round | Raised |
|---|---|---|---|
FogPharma |
March, 05 ,2024 | Series E | $145,000,000 |
Aeovian Pharmaceuticals |
December, 17 ,2025 | Unknown | $55,000,000 |
R1 Therapeutics |
March, 18 ,2026 | Series A | $77,500,000 |
FogPharma
Aeovian Pharmaceuticals
R1 Therapeutics
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Quorus | $5,000,000 | (Mar 18, 2026)
Turquoise(US) | $40,000,000 | (Mar 18, 2026)
Conduit Health | $17,000,000 | (Mar 18, 2026)
iDEL Therapeutics GmbH | $10,381,635 | (Mar 18, 2026)